Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Posted on by Pencis

Prof. Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Fuzhou University Affiliated Provincial Hospital | China

Author Profile

Scopus

Orcid ID

🎓 THE REMARKABLE JOURNEY OF FU-SHAN XUE: A TRAILBLAZER IN ANESTHESIOLOGY

🎓 EARLY ACADEMIC PURSUITS

Fu-Shan Xue’s academic journey laid a strong foundation for his outstanding future career. His deep passion for medical sciences, particularly anesthesiology and surgery, led him to pursue rigorous academic training, culminating in his appointment as a Doctoral Supervisor. His dedication during his formative academic years built the groundwork for his later roles as a Chief Physician and Distinguished Professor at Beijing Anzhen Hospital, Capital Medical University.

🏥 PROFESSIONAL ENDEAVORS

Dr. Xue’s professional career is marked by exceptional achievements and prestigious appointments. Serving as the Chief Physician and Professor at the Anesthesiology and Surgery Center of Beijing Anzhen Hospital, he became one of the leading figures in the field. Beyond his hospital responsibilities, he has been recognized as:

  • National Candidate of the "New Century Millions of Talents Project",

  • Expert with Special Allowance of the State Council,

  • Young and Middle-Aged Expert with Outstanding National Contributions,

  • Leading Talent of the National "Ten-Thousand Talents Program".

These distinctions reflect his national and international stature as a pioneering anesthesiologist.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MEDICINE

Dr. Xue has significantly advanced the field of anesthesiology through his extensive research and innovation. His focus spans various critical areas, including:

  • Innovative techniques in anesthesia and perioperative medicine,

  • Enhancing patient safety during surgical procedures,

  • Developing new surgical and anesthetic methodologies.

His contributions have led to real-world advancements in clinical practices, making surgeries safer and improving patient outcomes.

🌍 IMPACT AND INFLUENCE

The impact of Dr. Xue’s work extends far beyond the walls of his institution:

  • Published more than 1,180 academic papers, including over 830 as the first and corresponding author in SCI-indexed journals,

  • Edited and translated 15 professional books that serve as key references in the field,

  • Achieved 86 national patents (including 11 invention patents) and 10 foreign patents,

  • Honored with 8 prestigious awards at the provincial and ministerial levels.

Dr. Xue’s influence resonates through medical education, research innovation, and clinical excellence in China and globally.

📈 ACADEMIC CITATIONS

Given his prolific research output, Dr. Xue’s work has been widely cited across national and international medical communities. His extensive citation record demonstrates the foundational importance of his research in advancing anesthesiology and surgery disciplines. He stands as a major reference point for upcoming anesthesiologists and researchers worldwide.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Fu-Shan Xue’s legacy is already deeply entrenched in the history of anesthesiology:

  • A pioneer in bridging clinical practice and innovative research,

  • A mentor to new generations of physicians and researchers,

  • An architect of safer and more effective anesthesia practices.

Looking ahead, Dr. Xue continues to drive cutting-edge innovations, pursue international collaborations, and mentor young talents. His future contributions are expected to further revolutionize perioperative medicine, enhance global surgical standards, and inspire countless young professionals to follow in his footsteps.

🏅 AWARDS AND HONORS

  • China Distinguished Research Award of Anaesthesia

  • China Distinguishable Anaesthetist Award

  • Wu Yang Medical Medicine Award

  • Nie Jiedong Medical Award

  • Health Defender of Healthy China

  • Top 10 Innovative Medical Experts

These accolades underscore his unparalleled contributions to the advancement of medical science and patient care.

📑NOTABLE PUBLICATIONS

"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury" 

  • Authors: X., Li, Xintao , X., Li, Xinyue , T., Tian, Tian , M., Jin, Mu , F., Xue, Fushan
  • Journal: Redox Biology
  • Year: 2025

"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy" 

  • Authors: Y., Gao, Ying , L., Li, Lu , F., Zhao, Fang , M., Jin, Mu , F., Xue, Fushan
  • Journal: Drug Design, Development and Therapy
  • Year: 2025

"Subglottic airway injury during fiberscope-monitored intubation with a supraglottic airway device: A randomized controlled comparison of three tracheal tubes" 

  • Authors: K., Su, Kai , S., Xu, Shangjun , H., Wang, Haixia , F., Xue, Fushan , M., Tian
  • Journal: Ming Chinese Medical Journal
  • Year: 2025

Anish Maskey | Staphylococcus Aureus | Best Researcher Award

Posted on by Pencis

Dr. Anish Maskey | Staphylococcus Aureus | Best Researcher Award

New York Medical College | United States

Author Profile

Scopus

Orcid ID

Google Scholar

🌟 Dr. Anish R. Maskey, Ph.D. - Postdoctoral Fellow and Immunology Innovator

📚 EARLY ACADEMIC PURSUITS

Dr. Anish R. Maskey's academic journey began in Kathmandu, Nepal, where he earned a Bachelor of Science in 2016 from the Institute of Medicine. With a robust foundation in science, he pursued a Ph.D. in Pathology, Microbiology, and Immunology at New York Medical College, achieving an impressive CGPA of 3.75/4. His early education set the stage for a distinguished career in immunology, preparing him to tackle complex health challenges with innovative research approaches.

🧪 PROFESSIONAL ENDEAVORS

Currently a Postdoctoral Fellow in the Department of Pathology, Microbiology, and Immunology at New York Medical College, Dr. Maskey is mentored by Dr. Xiu-Min Li and focuses on pioneering research in immunology. His professional roles have spanned several collaborative and high-impact projects, including co-investigating clinical biomarker studies and leading efforts in immuno-oncology research related to chronic inflammatory and infectious diseases. Dr. Maskey’s work is characterized by his adept handling of sophisticated scientific techniques and a commitment to developing therapeutic strategies for challenging medical conditions.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON STAPHYLOCOCCUS AUREUS

Dr. Maskey's research contributions are extensive, with key focuses including:

  • B and T Cell Immunology: He has a deep-rooted expertise in investigating immune responses, particularly in relation to B and T cell functions in chronic inflammatory diseases and immuno-oncology.
  • Biomarker Studies in Allergy and Inflammation: His work on Traditional Chinese Medicine (TCM) involves understanding immune response markers in allergic diseases, the role of cytokines, and immune regulation, potentially offering new therapies for conditions such as eczema and food allergies.
  • Natural Compounds Against Antibiotic-Resistant Bacteria: In his role as Co-Principal Investigator, he has advanced research into natural compounds to combat antibiotic-resistant Staphylococcus aureus in both murine and humanized models.
  • Nanoparticle Immunotherapy: Dr. Maskey's study of berberine nanoparticles is pivotal in food allergy research, exploring mechanisms to suppress IgE-mediated allergic responses.

🌍 IMPACT AND INFLUENCE

Dr. Maskey's influence extends beyond the lab. His dedication to innovative research has earned him recognition through numerous awards, such as the AAAAI Ph.D. Travel Scholarships (2022-2024), the ASBMB Travel Award, and commendations for his scientific presentations. His involvement in conferences has facilitated cross-border collaborations, particularly between the U.S., India, and China, emphasizing his commitment to global health solutions. He is actively involved with organizations like the American Society for Microbiology and the American Academy of Allergy, Asthma, and Immunology, reflecting his dedication to community and professional engagement in the immunology field.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

With his research published in high-impact journals, Dr. Maskey's contributions to immunology are recognized and respected. He has authored numerous papers and serves as a peer reviewer for journals like The FASEB Journal, Cell Press, and Dove Medical Press. His scholarly output includes first-author publications, institutional presentations, and national conference contributions, underscoring his commitment to advancing immunology research.

🏅 HONORS & AWARDS

  • AAAAI Ph.D. Travel Scholarship (2022-2024)
  • Outstanding Abstract Award at Touro Research Day (2024)
  • Science in a Flash Runner-Up by ASBMB (2022)
  • Outstanding Scientific Poster at MIT's Future of Health Technology Summit (2019)

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Maskey’s legacy in immunology is still unfolding, with his promising work paving the way for future advancements in immunotherapy and natural medicine. His research on TCM, immune biomarkers, and nanoparticle technology is expected to yield novel treatment methods for allergies, chronic inflammation, and infectious diseases. Additionally, his role as a mentor to young scientists and his involvement in developing educational materials ensure his impact will resonate through future generations of researchers and clinicians.

🌠 FINAL NOTE

Dr. Anish R. Maskey embodies the spirit of a dedicated scientist and innovator, leveraging his expertise to improve human health. His work in immunology and microbiology is not only a testament to his skill but also his passion for creating lasting changes in medicine and science. With a promising future, Dr. Maskey continues to contribute meaningfully to the scientific community and inspire his peers and students alike.

📑 NOTABLE PUBLICATIONS 

"Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways" 

  • Authors: Maskey, A.R. , Kopulos, D. , Kwan, M. , Geliebter, J. , Li, X.-M.
  • Journal: Cells
  • Year: 2024

"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations" 

  • Authors: Maskey, A.R. , Mo, X. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation" 

  • Authors: Wang, Z.-Z. , Li, H. , Maskey, A.R. , Sampson, H.A. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell" 

  • Authors: Yang, N. , Srivastava, K. , Chen, Y. , Zhan, J. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2024

"Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation" 

  • Authors: Yang, N. , Maskey, A.R. , Srivastava, K. , Sampson, H.A. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2023